Periodic Reporting for period 2 - TARGET (Targeting DNA repair pathways, sparking anti cancer immunity)

TARGET aims at testing for the first time the hypothesis that therapeutic inactivation of DNA repair pathways in cancer cells can be exploited for patient benefit by reawakening an anti-tumor immune response against cancer cells. Colorectal cancer (CRC) is one of the leading...